Literature DB >> 6843791

Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat.

S J Cooper.   

Abstract

Both naloxone (3 and 10 mg X kg-1) and naltrexone (1-10 mg X kg-1) abolished the preference for a highly palatable 0.05% sodium saccharin solution in rats that had been adapted to a 22 hr water-deprivation schedule. The effect occurred as a result of a selective decrease in the consumption of the saccharin solution, since the intake of water, which was concurrently available in the two-fluid choice test, remained unaffected. When a less preferred saccharin solution was used (0.01%), naltrexone exerted a similar suppressant effect on the sodium preference, whilst naloxone failed to produce significant effects on the intake of saccharin solution or water. The data for the opiate agonists were interpreted in terms of a drug-induced blockade of the natural reward of highly palatable fluids in thirsty rats. In the same choice test, morphine and a stabilised enkephalin analogue, with a selective agonist action at mu-opiate receptors (RX783030), failed to influence the preference for the palatable saccharin solutions. In water-deprived animals, at least, exogenous opiate agonists, active at mu-receptors, did not appear to influence the reward of the palatable solutions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843791     DOI: 10.1016/0028-3908(83)90247-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  19 in total

1.  Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.

Authors:  K J Wong; F H W Wojnicki; R L W Corwin
Journal:  Pharmacol Biochem Behav       Date:  2009-02-13       Impact factor: 3.533

2.  A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training.

Authors:  Eric Augier; Russell S Dulman; Erick Singley; Markus Heilig
Journal:  J Vis Exp       Date:  2017-01-29       Impact factor: 1.355

3.  Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats.

Authors:  M E Carroll; S T Lac
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network.

Authors:  M J Will; E B Franzblau; A E Kelley
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

5.  Opioid mediation of starch and sugar preference in the rat.

Authors:  Kristine B Bonacchi; Karen Ackroff; Khalid Touzani; Richard J Bodnar; Anthony Sclafani
Journal:  Pharmacol Biochem Behav       Date:  2010-07-23       Impact factor: 3.533

6.  Opioid receptor antagonism in the nucleus accumbens fails to block the expression of sugar-conditioned flavor preferences in rats.

Authors:  Sonia Y Bernal; Khalid Touzani; Meri Gerges; Yana Abayev; Anthony Sclafani; Richard J Bodnar
Journal:  Pharmacol Biochem Behav       Date:  2009-12-13       Impact factor: 3.533

Review 7.  Ventral pallidum roles in reward and motivation.

Authors:  Kyle S Smith; Amy J Tindell; J Wayne Aldridge; Kent C Berridge
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

8.  Naloxone effects on sucrose-motivated behavior.

Authors:  J Cleary; D T Weldon; E O'Hare; C Billington; A S Levine
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

9.  Contributions of taste factors and gender to opioid preference in C57BL and DBA mice.

Authors:  M L Forgie; B L Beyerstein; B K Alexander
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Behavioral characterization of amygdala involvement in mediating intra-accumbens opioid-driven feeding behavior.

Authors:  Matthew J Will; Carolyn E Pritchett; Kyle E Parker; A M Sawani; H Ma; Annie Y Lai
Journal:  Behav Neurosci       Date:  2009-08       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.